In tumor cells expressing Pgp, the efflux of a given anticancer drug increases across the plasma membrane, thereby reducing the intracellular drug concentration and hence its cytotoxicity; Pgp activity can be reversed by a few specific molecules, referred to as MDR modulators. The gene discussed is PGP; the disease is neoplasm.